Clinical Trial Update: Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nab-paclitaxel and carboplatin followed by response-based local therapy for HPV-related oropharyngeal cancer (Stage III–IV) has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hpv-related Oropharyngeal Cancer
• Oropharyngeal Cancer
• Oropharyngeal Squamous Cell Carcinoma

Drugs mentioned

• Abraxane (nab-paclitaxel) (nab-paclitaxel)
• Carboplatin (Paraplatin) (carboplatin)

Snippet

Sponsor: University of Chicago | Conditions: Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx | Phase 2 | Status: COMPLETED | Results posted: 2021-01-08